Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.78M | -2.22M | -3.07M | 3.51M | -2.28M |
| Total Depreciation and Amortization | 15.60K | 8.50K | 8.50K | 8.50K | 8.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.10K | -198.30K | -9.60K | -75.50K | -222.30K |
| Change in Net Operating Assets | -72.80K | -424.30K | 571.90K | -1.04M | 474.30K |
| Cash from Operations | 1.70M | -2.83M | -2.50M | 2.41M | -2.02M |
| Capital Expenditure | -10.00K | -80.10K | -- | -- | -9.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 771.10K | 1.10M | 4.75M | -4.09M | 2.74M |
| Cash from Investing | 761.10K | 1.02M | 4.75M | -4.09M | 2.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 209.30K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -5.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 8.10K | -8.10K | -- |
| Cash from Financing | 0.00 | 0.00 | 217.40K | -8.10K | -5.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.46M | -1.81M | 2.47M | -1.69M | 699.10K |